Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Multiple Sclerosis and Related Disorders|June 19, 2022
The effect of timing of high-efficacy therapy on processing speed performance in multiple sclerosisAndrés Labiano-Fontcuberta, Lucienne Costa-Frossard, Susana Sainz de la Maza, et al.Multiple Sclerosis and Related Disorders|June 25, 2023
Predictive models of multiple sclerosis-related cognitive performance using routine clinical practice predictorsAndrés Labiano-Fontcuberta, Lucienne Costa-Frossard, Susana Sainz de la Maza, et al.Movement Disorders Clinical Practice|January 11, 2021
Does the Country Make a Difference in Impulse Control Disorders? A Systematic ReviewPaloma Parra-Díaz, Juan Luis Chico-García, Álvaro Beltrán-Corbellini, et al.Frontiers in Immunology|May 27, 2026
Clinical and laboratory findings in patients with anti-myelin oligodendrocyte glycoprotein antibodies: experience from two tertiary hospitals in MadridSara Muñoz-Gómez, Roberto Pariente-Rodríguez, Juan Luis Chico-García, et al.Seizure|August 7, 2023
Cenobamate in patients with highly refractory focal epilepsy: A retrospective real-world studyÁlvaro Beltrán-Corbellini, María Romeral-Jiménez, Pablo Mayo, et al.Multiple Sclerosis and Related Disorders|October 21, 2022
B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximabJuan Luis Chico-García, Fernando Rodríguez-Jorge, Raquel Sainz-Amo, et al.Frontiers in Immunology|September 6, 2024
COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosisSusana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 2, 2021
Malignant Left Atrial Appendage Morphology: Current Classification vs H-L SystemPaloma Parra-Díaz, Luisa Salido-Tahoces, Ana Pardo-Sanz, et al.Cerebrovascular Diseases Extra|November 11, 2020
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 PatientsVictoria Ros-Castelló, Elena Natera-Villalba, Ana Gómez-López, et al.Vaccines|September 28, 2023
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 VaccineAlexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, et al.Pageof 2